Literature DB >> 11712098

Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.

A Karim1, S Ahmed, L J Rossoff, R K Siddiqui, H N Steinberg.   

Abstract

Levofloxacin is one of the most commonly prescribed antibiotics for both inpatient and outpatient care of respiratory tract infection. It is generally well tolerated, and it has an excellent safety profile. We report a case of severe acute liver toxicity that apparently complicated intravenous administration of levofloxacin, which resolved after discontinuation of the drug.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11712098     DOI： 10.1086/338156

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

2.  Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.

Authors:  Jon-David Schwalm; Christine H Lee
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

Review 3.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

4.  Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

Authors:  Peter Ball
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

Review 5.  Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors:  Françoise Van Bambeke; Paul M Tulkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  [Parasitic dermatoses from abroad].

Authors:  Robert Rongisch; Luisa Bopp; Mario Fabri; Esther von Stebut
Journal:  Hautarzt       Date:  2021-02       Impact factor: 0.751

Review 7.  Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Authors:  Anna Licata; Claudia Randazzo; Ilaria Morreale; Giuseppe Butera; Natale D'Alessandro; Antonio Craxì
Journal:  Eur J Clin Pharmacol       Date:  2012-01-14       Impact factor: 3.064

Review 8.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

9.  A Case of Levofloxacin-Induced Hepatotoxicity.

Authors:  Michael Schloss; Daniel Becak; Sebastian T Tosto; Arash Velayati
Journal:  Am J Case Rep       Date:  2018-03-10

10.  Hepatotoxicity Secondary to Levofloxacin Use.

Authors:  Ladan Panahi; Salim Surani Surani; George Udeani; Niraj P Patel; Jacob Sellers
Journal:  Cureus       Date:  2021-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.